Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 2909-2913

  Aizat, Abdul Aziz Ahmad ^a   Shahpudin, Siti Nurfatimah Mohd ^a   Mustapha, Mohd Aminudin ^a   Zakaria, Zaidi ^b   Sidek, Ahmad Shanwani Mohd ^b   Hassan, Muhammad Radzi Abu ^c   Ankathil, Ravindran ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b Hospital Raja Perempuan Zainab II   (Malaysia)

^c HOSPITAL SULTANAH BAHIYAH   (Malaysia)

Author keywords

Colorectal cancer; Malaysia; TP53 codon 72

Indexed keywords

EID: 84863329124     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cao Z, Song JH, Park YK, et al.(2009). The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma, 56, 114-8.
2. De La Chapelle, A. (2004). Genetic predisposition to colorectal cancer. Nat Rev Cancer, 4, 769-80.
3. Dumont P, Leu JI, Della Pietra AC, et al. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 33, 357-65.
4. Economopoulos KP, Sergentanis TN, Zagouri F, et al. (2010). Association between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis. Onkologie, 33, 666-74.
5. Giovannucci E (2001). An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 10, 725-31.
6. Joshi AM, Budhathoki S, Ohnaka K, et al. (2010). TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Jpn J Clin Oncol, 41, 232-8.
7. Koushik A, Tranah GJ, Ma J, et al. (2006). p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer, 119, 1863-8.
8. Kressner U, Inganas M, Byding S et al. (1999). Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol, 17, 593-9.
9. Lima-Ramos V, Pacheco-Figueiredo L, Costa S, et al. (2008). TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet, 180, 14-9.
10. Malaysia Cancer Statistics (2006): Data and Figures Peninsular Malaysia. IN REGISTRY, N. C. (Ed.). Kuala Lumpur.
11. Mammano E, Belluco C, Bonafe M, et al. (2009). Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol, 35, 415-9.
12. Marin MC, Jost CA, Brooks LA, et al. (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet, 25, 47-54.
13. Matlashewski GJ, Tuck S, Pim D, et al. (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 7, 961-3.
14. Neagoe A, Molnar AM, Acalovschi M, et al. (2004). Risk factors for colorectal cancer: an epidemiologic descriptive study of a series of 333 patients. Rom J Gastroenterol, 13, 187-93.
15. Perez LO, Abba MC, Dulout FN, et al. (2006). Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol, 12, 1426-9.
16. Pim D, Banks L, (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer, 108, 196-9.
17. Sameer AS, Shah ZA, Syeed N, et al. (2010). TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res, 9, 651-60.
18. Stern MC, Conti DV, Siegmund KD, et al (2007). DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev, 16, 2363-72.
19. Tang NP, Wu YM, Wang B, et al. (2010). Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol, 36, 431-8.
20. Tenesa A, Farrington SM, Prendergast JG, et al. (2008). Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet, 40, 631-7.
21. Terry P, Giovannucci E, Michels KB, et al. (2001). Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst, 93, 525-33.
22. Thomas M, Kalita A, Labrecque S, et al. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100.
23. Tomlinson IP, Webb E, Carvajal-Carmona L, et al. (2008). A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet, 40, 623-30.
24. Tommasino M, Accardi R, Caldeira S, et al. (2003). The role of TP53 in Cervical carcinogenesis. Hum Mutat, 21, 307-12.
25. Van Heemst D, Mooijaart SP, Beekman M, et al. (2005). Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol, 40, 11-5.
26. Vogelstein B, Kinzler KW (1992). p53 function and dysfunction. Cell, 70, 523-6.
27. Yeh CC, Hsieh LL, Tang R, et al. (2005). MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan. Cancer Lett, 224, 279-88.
28. Zhu ZZ, Wang AZ, Jia HR, et al. (2007). Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol, 37, 385-90.